Physician profile
Gregory Powell
NPI 1780677815
$964.24
in general payments reported to CMS, 2019-2025
14 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.37 · 2021: $39.64 · 2022: $198 · 2023: $163 · 2024: $256 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $228.50 | 2022-2025 | Relistor |
| Abbott Laboratories | $155.14 | 2021-2025 | Proclaim, Octrode, Eterna |
| Nevro Corp. | $151.47 | 2022-2024 | Senza |
| Boston Scientific Corporation | $148.78 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Ossur Americas, INC. | $54.56 | 2025 | |
| Pacira Therapeutics, INC. | $37.37 | 2019 | |
| Scilex Pharmaceuticals INC. | $33.46 | 2022 | |
| Ermi LLC | $32.00 | 2019 | |
| Vericel Corporation | $26.28 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $25.46 | 2025 | |
| Avanos Medical | $23.50 | 2023 | Generator |
| Ibsa Pharma INC. | $18.41 | 2021 | |
| Valinor Pharma, LLC | $15.76 | 2025 | Movantik |
| Depuy Synthes Sales INC. | $13.55 | 2023 | Monovisc, Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.